Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study

doi:10.3748/wjg.v11.i4.482

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2638)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-9) series.

Item

Count

PDF

264

HTML

2225

Tables (1-9)

149

Sum=2638

Jan 28, 2005 (publication date) through May 30, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jan 28, 2005; 11(4): 482-487
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.482

Table 6 Impact of PCA on sustained virological response of the patients.

	Virological response at the end of follow up [n (%)]
	n	Yes	No	P
PCA entry
Pos	9	0 (0)	9 (100)	0.02
Neg	48	20 (41.7)	28 (58.3)

Abbreviations are same as in the text. n = the number of individuals in each group, P values were calculated by Fischer’s exact test or χ² where applicable.

Citation: Gatselis NK, Georgiadou SP, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study. World J Gastroenterol 2005; 11(4): 482-487
URL: https://www.wjgnet.com/1007-9327/full/v11/i4/482.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i4.482